February 12, 2008
Lohmann introduces vaccine to provide maternal antibodies to breeder hens
Press release
Lohmann Animal Health recently introduced the AviPro 226 BTO2-REO vaccine to be used for the vaccination of breeder hens.
The vaccine acts as replacement pullets to provide maternal antibodies for early protection of progeny against reovirus-related malabsorption syndrome, tenosynovitis, and type 1 infectious bursal disease, standard and variant strains.
|
Lohmann's BTO2-REO contains the standard challenge strain and the Delaware variant 1084E strain of infectious bursal disease virus as well as strains of S1133 and 1733 of avian reovirus.
The product is available in a 1000-dose bottle for SQ injection of 0.5 ml per dose.
Birds should be primed with live tenosynovitis virus and bursal disease vaccines at least four weeks prior to the use of this vaccine.
Vaccination should take place between 12 and 20 weeks of age. Re-vaccination should occur during molt.
Lohmann Animal Health is a member of the PHW Group, which comprises 35 companies that produce avian vaccines and poultry for the global market.
The company delivers solutions for modern livestock production and is an important contributor to animal health and productivity. |
|
